Influence of magnetic field on the spectra of optical effects in magnetic fluids with different aggregative stability
Известия Российской академии наук. Серия физическая / Bulletin of the Russian Academy of Sciences: Physics · 2025 · 89 (7) · 1014
DOI: 10.7868/s3034646025070022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Известия Российской академии наук. Серия физическая / Bulletin of the Russian Academy of Sciences: Physics, 2025. Verfasst von V. I. Vivchar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The spectra of the effects of birefringence, dichroism and transmission spectra of magnetic fluids with different aggregative stability under the influence of a constant magnetic field were experimentally studied. A change in the complex refractive index of aggregates of magnetite nanoparticles during their growth was discovered. An interpretation of the spectral features of optical anisotropy and light transmission in aggregation-unstable magnetic fluids is proposed.
Zitieren
APA
Vivchar, V. I., & Yerin, C. V. (2025). Influence of magnetic field on the spectra of optical effects in magnetic fluids with different aggregative stability. Известия Российской академии наук. Серия физическая / Bulletin of the Russian Academy of Sciences: Physics, 89(7), 1014. https://doi.org/10.7868/s3034646025070022
Vancouver
Vivchar VI, Yerin CV. Influence of magnetic field on the spectra of optical effects in magnetic fluids with different aggregative stability. Известия Российской академии наук. Серия физическая / Bulletin of the Russian Academy of Sciences: Physics. 2025;89(7):1014. doi:10.7868/s3034646025070022
BibTeX
@article{Vivchar2025,
author = {Vivchar, V. I. and Yerin, C. V.},
title = {Influence of magnetic field on the spectra of optical effects in magnetic fluids with different aggregative stability},
journal = {Известия Российской академии наук. Серия физическая / Bulletin of the Russian Academy of Sciences: Physics},
year = {2025},
volume = {89},
number = {7},
pages = {1014},
doi = {10.7868/s3034646025070022}
}
EUVIMED